Cargando...
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
OBJECTIVES: : Novel treatments for hepatitis C demonstrate high cure rates, but current high prices can be a barrier to rapid global treatment scale-up. Generic competition can rapidly lower drug prices. Using data on exports of raw materials in 2015, we calculated currently feasible generic prices...
Gardado en:
| Publicado en: | J Virus Erad |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Mediscript Ltd
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946692/ https://ncbi.nlm.nih.gov/pubmed/27482432 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|